BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 35741019)

  • 1. Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review.
    Bose M; Yergeau C; D'Souza Y; Cuthbertson DD; Lopez MJ; Smolen AK; Braverman NE
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic challenges and disease management in patients with a mild Zellweger spectrum disorder phenotype.
    Enns GM; Ammous Z; Himes RW; Nogueira J; Palle S; Sullivan M; Ramirez C
    Mol Genet Metab; 2021 Nov; 134(3):217-222. PubMed ID: 34625341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zellweger Spectrum Disorder: Ophthalmic Findings from a New Natural History Study Cohort and Scoping Literature Review.
    Yergeau C; Coussa RG; Antaki F; Argyriou C; Koenekoop RK; Braverman NE
    Ophthalmology; 2023 Dec; 130(12):1313-1326. PubMed ID: 37541626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
    Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
    J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants.
    Lipiński P; Stawiński P; Rydzanicz M; Wypchło M; Płoski R; Stradomska TJ; Jurkiewicz E; Ferdinandusse S; Wanders RJA; Vaz FM; Tylki-Szymańska A
    J Appl Genet; 2020 Feb; 61(1):87-91. PubMed ID: 31628608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregivers.
    Bose M; Cuthbertson DD; Fraser MA; Roullet JB; Gibson KM; Schules DR; Gawron KM; Gamble MB; Sacra KM; Lopez MJ; Rizzo WB
    Mol Genet Metab Rep; 2020 Dec; 25():100694. PubMed ID: 33335840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese patients with adrenoleukodystrophy and Zellweger spectrum disorder presenting with hereditary spastic paraplegia.
    Chen YJ; Wang MW; Dong EL; Lin XH; Wang N; Zhang ZQ; Lin X; Chen WJ
    Parkinsonism Relat Disord; 2019 Aug; 65():256-260. PubMed ID: 31227335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome biogenesis disorders in the Zellweger spectrum: An overview of current diagnosis, clinical manifestations, and treatment guidelines.
    Braverman NE; Raymond GV; Rizzo WB; Moser AB; Wilkinson ME; Stone EM; Steinberg SJ; Wangler MF; Rush ET; Hacia JG; Bose M
    Mol Genet Metab; 2016 Mar; 117(3):313-21. PubMed ID: 26750748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Study of Hearing Loss in Patients Diagnosed with Peroxisome Biogenesis Disorders in the Zellweger Spectrum.
    Lee J; Yergeau C; Kawai K; Braverman N; Géléoc GSG
    Ear Hear; 2022; 43(2):582-591. PubMed ID: 34534157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pex1-G844D mouse: a model for mild human Zellweger spectrum disorder.
    Hiebler S; Masuda T; Hacia JG; Moser AB; Faust PL; Liu A; Chowdhury N; Huang N; Lauer A; Bennett J; Watkins PA; Zack DJ; Braverman NE; Raymond GV; Steinberg SJ
    Mol Genet Metab; 2014 Apr; 111(4):522-532. PubMed ID: 24503136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal study of Pex1-G844D NMRI mouse model: A robust pre-clinical model for mild Zellweger spectrum disorder.
    Demaret T; Roumain M; Ambroise J; Evraerts J; Ravau J; Bouzin C; Bearzatto B; Gala JL; Stepman H; Marie S; Vincent MF; Muccioli GG; Najimi M; Sokal EM
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165900. PubMed ID: 32693164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a severity scoring system for Zellweger spectrum disorders.
    Klouwer FCC; Meester-Delver A; Vaz FM; Waterham HR; Hennekam RCM; Poll-The BT
    Clin Genet; 2018 Mar; 93(3):613-621. PubMed ID: 28857144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers.
    Wangler MF; Hubert L; Donti TR; Ventura MJ; Miller MJ; Braverman N; Gawron K; Bose M; Moser AB; Jones RO; Rizzo WB; Sutton VR; Sun Q; Kennedy AD; Elsea SH
    Genet Med; 2018 Oct; 20(10):1274-1283. PubMed ID: 29419819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homozygous Gly470Ala variant in PEX6 causes severe Zellweger spectrum disorder.
    Galarreta CI; Wong K; Carmichael J; Woods J; Tise CG; Niehaus AD; Schildt AJ; Verscaj CP; Cusmano-Ozog KP
    Am J Med Genet A; 2023 Aug; 191(8):2057-2063. PubMed ID: 37144748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Zellweger syndrome caused by PEX6 gene variation in 2 cases and literature review].
    Yang P; Zeng CZ; Tao XW; Rong SW; Long Y; Zeng LK
    Zhonghua Er Ke Za Zhi; 2024 Jan; 62(1):43-48. PubMed ID: 38154976
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver disease predominates in a mouse model for mild human Zellweger spectrum disorder.
    Berendse K; Boek M; Gijbels M; Van der Wel NN; Klouwer FC; van den Bergh-Weerman MA; Shinde AB; Ofman R; Poll-The BT; Houten SM; Baes M; Wanders RJA; Waterham HR
    Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2774-2787. PubMed ID: 31207289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two novel mutations of
    Yu HL; Shen Y; Sun YM; Zhang Y
    Ann Transl Med; 2019 Aug; 7(16):368. PubMed ID: 31555682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mild form of Zellweger Spectrum Disorders (ZSD) due to variants in
    Barillari MR; Karali M; Di Iorio V; Contaldo M; Piccolo V; Esposito M; Costa G; Argenziano G; Serpico R; Carotenuto M; Cappuccio G; Banfi S; Melillo P; Simonelli F
    Mol Genet Metab Rep; 2020 Sep; 24():100615. PubMed ID: 32596134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zellweger Syndrome Disorders: From Severe Neonatal Disease to Atypical Adult Presentation.
    Cheillan D
    Adv Exp Med Biol; 2020; 1299():71-80. PubMed ID: 33417208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipidomic analysis of fibroblasts from Zellweger spectrum disorder patients identifies disease-specific phospholipid ratios.
    Herzog K; Pras-Raves ML; Vervaart MA; Luyf AC; van Kampen AH; Wanders RJ; Waterham HR; Vaz FM
    J Lipid Res; 2016 Aug; 57(8):1447-54. PubMed ID: 27284103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.